6446 PharmaEssentia
NQ Score
44/100
N1 Content Completeness
9
AI Summary (NQ-processed)
PharmaEssentia announced on May 25, 2026, the completion of a capital reduction by canceling restricted employee shares. The reduction involves 8,000 shares, with minimal impact on financial statements.
AI Analysis
Frequently Asked Questions
- Q: What is the purpose of the capital reduction?
- A: To cancel restricted employee shares.